Schering boss hits out at mergers as diagnostics falters
This article was originally published in Clinica
Executive Summary
The chairman of the German company Schering, Dr Giuseppe Vita, has attacked the rush to merge and claims that Schering will remain independent, based on its strengths in niche markets, notably diagnostics.